NATH BIO-GENES (I) LTD (NATHBIOGEN)

NSE: ₹173.09
BSE: ₹173.90
Stock Performance
Corporate Announcements
No recent announcements available.

Quarterly Financials

Consolidated Standalone
Particulars Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Revenue from Operations 235.28 22.57 31.74 43.04 243.88 32.19 36.87 51.97 283.70 43.85 65.96 51.59
YOY Revenue Growth % - - - -4.33% 3.65% 42.65% 16.18% 20.75% 16.33% 36.21% 78.88% -0.72%
Other Income 0.12 0.06 0.04 0.41 0.13 0.08 0.48 3.86 1.76 1.93 1.74 2.38
Total Income 235.40 22.63 31.78 43.45 244.01 32.27 37.35 55.83 285.46 45.78 67.69 53.97
Total Expenses + 202.00 20.25 29.69 41.16 210.41 31.18 33.56 54.26 249.59 42.39 67.90 52.74
Cost of Materials Consumed 69.42 5.66 8.36 59.02 66.39 0.69 86.87 101.60 108.85 21.80 106.33 69.20
Employee Benefit Expense 7.19 7.85 5.99 7.17 6.74 8.94 10.49 6.34 9.59 10.39 11.61 4.21
Other Expenses 68.50 4.96 5.97 41.00 77.69 5.98 5.86 27.53 96.00 10.25 22.00 27.11
Operating Profit 33.28 2.32 2.05 1.87 33.47 1.01 3.31 -2.29 34.11 1.46 -1.94 -1.14
OPM % 14.1% 10.3% 6.5% 4.4% 13.7% 3.1% 9% -4.4% 12% 3.3% -2.9% -2.2%
Profit Before Tax + 33.40 2.38 4.59 3.23 33.60 1.09 3.79 2.11 37.94 5.46 2.48 2.49
Tax Expense 0.22 0.31 0.75 0.62 0.25 -0.03 1.14 0.63 0.66 2.70 0.87 2.50
Tax % 0.7% 13.1% 16.4% 19% 0.7% -2.5% 30.1% 29.8% 1.7% 49.6% 35.2% 100.4%
Profit After Tax 33.18 2.07 3.83 2.62 33.35 1.11 2.65 1.48 37.28 2.75 1.61 -0.01
EPS (Basic) 17.47 0.86 2.02 1.87 17.49 0.53 1.33 1.14 19.58 1.40 0.84 -0.79

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023
Revenue from Operations 445.10 364.91 332.62 301.36
YOY Revenue Growth % 21.98% 9.71% 10.37% -
Other Income 7.81 4.55 0.63 0.55
Total Income 452.91 369.45 333.25 301.92
Total Expenses + 412.62 329.41 295.13 265.75
Cost of Materials Consumed 306.18 225.54 142.47 117.32
Employee Benefit Expense 35.79 32.50 28.25 23.32
Other Expenses 155.37 147.06 120.94 94.69
Operating Profit 32.49 35.50 37.49 35.61
OPM % 7.3% 9.7% 11.3% 11.8%
Profit Before Exceptional 40.30 40.04 38.12 36.16
Exceptional Items 6.01 0.54 3.45 0.00
Profit Before Tax + 46.30 40.58 41.57 36.16
Tax Expense 4.67 1.98 1.95 1.14
Tax % 10.1% 4.9% 4.7% 3.1%
Profit After Tax 41.63 38.60 39.62 35.03
EPS (Basic) 20.98 20.14 21.34 18.42

Balance Sheet

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023
ASSETS
Non-Current Assets + 318.56 336.20 308.57 271.97
Property, Plant & Equipment 243.80 243.19 240.65 233.96
Capital Work in Progress 0.00 0.00 0.00 0.00
Non-Current Investments 5.90 5.78 8.81 5.05
Goodwill 0.00 0.00 0.00 0.00
Other Intangible Assets 5.59 7.18 0.00 10.42
Current Assets + 778.86 690.01 571.66 520.83
Inventories 450.55 338.02 230.31 207.85
Trade Receivables 85.41 88.90 94.31 97.31
Cash and Cash Equivalents 76.00 88.90 77.41 38.00
Current Investments 0.00 0.00 0.00 0.00
LIABILITIES & EQUITY
Total Equity 680.46 644.39 609.92 573.17
Equity Share Capital 19.00 19.00 19.00 19.00
Other Equity 661.45 625.38 590.91 554.17
Non-Current Liabilities 22.27 16.52 7.87 3.17
Current Liabilities 394.70 365.30 262.45 216.45
Total Liabilities 416.96 381.82 270.31 219.62

Cash Flow Statement

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023
Cash from Operating Activities -12.57 17.58 70.28 38.37
Cash from Investing Activities 3.46 -3.96 -27.40 -2.88
Cash from Financing Activities -3.81 -2.13 -4.51 -1.67
Net Increase/Decrease in Cash -12.93 11.49 38.37 33.82